Bernard, Micah F.

Hickinbotham, Lia G.

Nelson, Casey A.

Rudy, Nicholas A.

Thornton, Phillip L.

Ward, Jessica A.

English

Digital Commons

Cedarville UniversityDigitalCommons@CedarvilleThe Research and Scholarship Symposium The 2013 SymposiumApr 10th, 1:00 PM - 5:00 PMAdherence to Type 2 Diabetes TreatmentMicah F. BernardCedarville University, mfbernard@cedarville.eduJessica A. WardCedarville University, jaward@cedarville.eduNicholas A. RudyCedarville University, nicholasarudy@cedarville.eduCasey A. NelsonCedarville University, caseyanelson@cedarville.eduLia G. HickinbothamCedarville University, liahickinbotham@cedarville.eduSee next page for additional authorsFollow this and additional works at: http://digitalcommons.cedarville.edu/research_scholarship_symposiumPart of the Endocrine System Diseases CommonsThis Poster is brought to you for free and open access byDigitalCommons@Cedarville, a service of the Centennial Library. It hasbeen accepted for inclusion in The Research and Scholarship Symposiumby an authorized administrator of DigitalCommons@Cedarville. For moreinformation, please contact digitalcommons@cedarville.edu.Bernard, Micah F.; Ward, Jessica A.; Rudy, Nicholas A.; Nelson, Casey A.; Hickinbotham, Lia G.; and Thornton, Phillip L., "Adherenceto Type 2 Diabetes Treatment" (2013). The Research and Scholarship Symposium. 46.http://digitalcommons.cedarville.edu/research_scholarship_symposium/2013/poster_presentations/46PresentersMicah F. Bernard, Jessica A. Ward, Nicholas A. Rudy, Casey A. Nelson, Lia G. Hickinbotham, and Phillip L.ThorntonThis poster is available at DigitalCommons@Cedarville: http://digitalcommons.cedarville.edu/research_scholarship_symposium/2013/poster_presentations/46Introduction              Background         Methods Results Conclusion References    1. Ciechanowski, P. S., W. J. Katon, J. E. Russo, and E. A.  Walker. "The Patient-Provider Relationship:  Attachment Theory and Adherence to Treatment in  Diabetes." The American Journal of Psychiatry  158.01 (2001): n. pag. Web. 12 Feb. 2013.  2. Grant, Richard W., Nicole G. Devita, Daniel E. Singer,  and James B. Meigs. "Diabetes Care." American  Diabetes Association 26.5 (2003): 1408-412. Print.   3. Morisky, Donald E., Alfonso Ang, Marie Krousel-Wood,  and Harry Wood. "Predictivity Validity of a  Medication Adherence Measure in an Outpatient  Setting." The Journal of Clinical Hypertension 10.5  (2008): 348-54. Le Jacq. Web. 23 Mar. 2013.   4. Rubin, Richard R. "Adherence to Pharmacologic  Therapy in Patients with Type 2 Diabetes Mellitus."  The American Journal of Medicine 118.5 (2005):    27-34. ScienceDirect. Web.   5. "Type 2 Diabetes." PubMed Health. U.S. National  Library of Medicine, 28 June 2011. Web. 2 Feb.  2013.         Purpose Previous studies suggest that the non-adherence rate is between 25-30% depending on the treatment type. Some of the leading causes of non-adherence were fear of side effects and a lack of confidence in the treatment plan’s effectiveness. Studies have not evaluated the impact that pharmacists have in improving adherence to diabetes management. This study aimed to assess compliance with and obstacles to medication treatment plan adherence in patients with Type 2 Diabetes, as well as determine possible steps pharmacists can take to increase rates.  Medication adherence is the measure of faithfulness to a treatment plan as prescribed by a physician. Patient adherence to medication administration is critical to obtaining desired results. Assessing compliance rates and obstacles that patients face can help pharmacists understand how to promote higher adherence. Understanding these obstacles is crucial because consistent failure to adhere to Diabetes Type 2 treatment can result in serious health problems such as nerve damage, blindness, and skin ulcerations.  An electronic survey was created, using the website Qualtrics, to assess the adherence tendencies of respondents with Type 2 Diabetes. The survey was sent by email to the faculty, staff, and students of Cedarville University, but only those who are currently using medication to treat Type 2 Diabetes were asked to participate. Twenty-eight responses were received and the data was analyzed using Qualtrics and Excel.    This study showed that 75% of respondents did not completely adhere to their treatment program. Some reasons for non-adherence determined were pain or discomfort, not remembering doses, taking multiple medications and losing track, difficulty in reading prescription labels or instructions, difficulty obtaining refills, low confidence in effectiveness of treatment plan, fear of side effects, and Based on this study, the leading factors in non-adherence were forgetfulness, busyness, and cost. Pharmacists who wish to combat the high non-adherence rate in those with Type 2 Diabetes should devise methods to help patients overcome these obstacles.      Adherence to Treatment Plan in Patients with Type 2 Diabetes      Micah Bernard, Lia Hickinbotham, Casey Nelson, Nicholas Rudy, Jessica Ward, Phillip Thornton, RPh, PhD preference for non-medical treatment. The most common reasons for noncompliance were forgetfulness, busyness, and cost of medication. Results showed that neither gender nor age had a significant impact on adherence rate.  012345678Number of Times  Reported Common Reasons for Non-Adherence  

Adherence to Type 2 Diabetes Treatment

https://digitalcommons.cedarville.edu/cgi/viewcontent.cgi?article=1076&context=research_scholarship_symposium

Adherence to Type 2 Diabetes Treatment

Abstract

Similar works

Full text

Available Versions

Digital Commons